Bianca Cheaib

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)

Soizick Mesnage, Aurélie Auguste, Catherine Genestie et al. · Annals of Oncology · 2016 · 171 citations · Full text

Cancer Immunosurveillance, Neoadjuvant Chemotherapy, Epithelial Ovarian Cancer +12

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial

Mónica Arnedos, Mohamed Amine Bayar, Bianca Cheaib et al. · Annals of Oncology · 2018 · 61 citations · Full text

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer

Alexandra Léary, Catherine Genestie, Félix Blanc‐Durand et al. · Cancer Immunology Immunotherapy · 2020 · 51 citations · Full text

Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?

Cristina Smolenschi, Elie Rassy, Johan Pallud et al. · Journal of Neurology · 2023 · 13 citations

Neuro-oncology, Medicine, Cancer Management +8

Abstract CT041: Anti-proliferative response and predictive biomarkers to palbociclib in early breast cancer: The Preoperative Palbociclib (POP) randomized trial

Mónica Arnedos, Bianca Cheaib, Mohamed Amine Bayar et al. · Cancer Research · 2016 · 12 citations

Breast Oncology, Pathology, Pharmacotherapy +20